| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |